Search Results for: CSDE1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel CDC7 cell division cycle 7
  • Activation of ATR in response to replication stress
  • Activation of the pre-replicative complex
  • Transcriptional Regulation by E2F6
Novel CTBS chitobiase
Novel DOK1 docking protein 1
  • PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
  • RET signaling
Novel DPYD dihydropyrimidine dehydrogenase
  • Pyrimidine catabolism
  • (5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione
  • NADPH
  • 6-Carboxymethyluracil
  • Flavin adenine dinucleotide
  • Flavin mononucleotide
  • Uracil
  • Eniluracil
  • 5-Iodouracil
  • Gimeracil
  • Tegafur-uracil
  • Dihydropyrimidine dehydrogenase deficiency
Novel GCKR glucokinase regulator
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
Novel GCNT1 glucosaminyl (N-acetyl) transferase 1
  • O-linked glycosylation of mucins
Novel GFI1 growth factor independent 1 transcriptional repressor
  • Transcriptional regulation of granulopoiesis
Novel IGFBP5 insulin like growth factor binding protein 5
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Novel KCNMB4 potassium calcium-activated channel subfamily M regulatory beta subunit 4
  • Ca2+ activated K+ channels
  • cGMP effects
  • Procaine
  • Miconazole
  • Trimebutine
Novel SH3GLB1 SH3 domain containing GRB2 like, endophilin B1
Novel SLIT2 slit guidance ligand 2
  • Netrin-1 signaling
  • Signaling by ROBO receptors
  • Signaling by ROBO receptors
  • Activation of RAC1
  • Regulation of commissural axon pathfinding by SLIT and ROBO
  • Inactivation of CDC42 and RAC1
  • Role of ABL in ROBO-SLIT signaling
  • Role of ABL in ROBO-SLIT signaling
  • SLIT2:ROBO1 increases RHOA activity
  • Regulation of expression of SLITs and ROBOs
  • Regulation of expression of SLITs and ROBOs
Novel SNRPB2 small nuclear ribonucleoprotein polypeptide B2
  • mRNA Splicing - Major Pathway
Novel WFS1 wolframin ER transmembrane glycoprotein
  • XBP1(S) activates chaperone genes
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Type II diabetes mellitus
  • Wolfram syndrome (WFS); DIDMOAD syndrome
C11orf68 chromosome 11 open reading frame 68
ERBB2 erb-b2 receptor tyrosine kinase 2
  • Signaling by ERBB2
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • GRB2 events in ERBB2 signaling
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Sema4D induced cell migration and growth-cone collapse
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Constitutive Signaling by Overexpressed ERBB2
  • Drug-mediated inhibition of ERBB2 signaling
  • Signaling by ERBB2 KD Mutants
  • Resistance of ERBB2 KD mutants to trastuzumab
  • Resistance of ERBB2 KD mutants to sapitinib
  • Resistance of ERBB2 KD mutants to tesevatinib
  • Resistance of ERBB2 KD mutants to neratinib
  • Resistance of ERBB2 KD mutants to osimertinib
  • Resistance of ERBB2 KD mutants to afatinib
  • Resistance of ERBB2 KD mutants to AEE788
  • Resistance of ERBB2 KD mutants to lapatinib
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Drug resistance in ERBB2 TMD/JMD mutants
  • Trastuzumab
  • Lapatinib
  • IGN311
  • Trastuzumab emtansine
  • Varlitinib
  • AV-412
  • Pertuzumab
  • Afatinib
  • Tucatinib
  • Tesevatinib
  • Fostamatinib
  • Brigatinib
  • Margetuximab
  • Zanubrutinib
  • Choriocarcinoma
  • Pancreatic cancer
  • Gastric cancer
  • Bladder cancer
  • Endometrial Cancer
  • Ovarian cancer
  • Cholangiocarcinoma
  • Breast cancer
  • Cervical cancer
FAM9B family with sequence similarity 9 member B
HID1 HID1 domain containing
HNRNPD heterogeneous nuclear ribonucleoprotein D
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
  • Artenimol
PABPC1 poly(A) binding protein cytoplasmic 1
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Deadenylation of mRNA
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • Translation initiation complex formation
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
PCSK7 proprotein convertase subtilisin/kexin type 7

Page 1 out of 2 pages